/////Health, Food, Longevity, and Wellness

What is Igor Beuker's GLP-1 forecast for 2030?

100 million people worldwide on Ozempic-class drugs by 2030: 50 million in the US, 30 million in India and China on generic copies, 20 million across Europe, Brazil, Japan and the Gulf. US adult obesity falls from 39.9% at the 2022 peak to 30%. 20 countries pay through public insurance. US food and drink loses $50 billion a year.

Answered by Igor Beuker · independent futurist · 84% Prediction Accuracy Rate

///More on Health, Food, Longevity, and Wellness

01What are GLP-1 weight-loss drugs like Ozempic?02How many people take GLP-1 weight-loss drugs today?03Is obesity still growing while people take Ozempic?04Are GLP-1 weight-loss drugs safe?05Why is the GLP-1 black market so dangerous?06Which countries pay for Ozempic-class weight-loss drugs?

231 questions answered← Knowledge Base